Payment overview · 2025
General Payments
$591.99
25 reported records · 10 companies
Healthcare provider profile · identity verified
Evgueni Roudachevski, DO
Allopathic & Osteopathic Physicians|Internal Medicine · LITTLE ROCK, AR · NPI 1215993787
Verified facts
What the public records show
CMS Open Payments records show Evgueni Roudachevski, DO received $591.99 in general payments during 2025 across 25 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 34.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 13 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza, Rexulti, Xifaxan, Zenpep.
Aimmune Therapeutics, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ZENPEP as an associated drug or biological on 32144 records involving 12432 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Zenpep by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Myrbetriq by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 55 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 67 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Symbicort by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Rexulti by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Ingrezza by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Xifaxan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $203.59 | 34.4% | 6 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $158.98 | 26.9% | 8 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $50.94 | 8.6% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $44.51 | 7.5% | 2 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $38.54 | 6.5% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $25.00 | 4.2% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $19.40 | 3.3% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $18.61 | 3.1% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.58 | 2.8% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $15.84 | 2.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $475.74 | 24 |
| Education | $116.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $117.51 | 6 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $72.29 | 4 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $50.94 | 2 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $44.51 | 2 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $41.47 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $25.00 | 1 | 2025 |
Source payment records
|
|||||
| VOWST Normalized: vowst |
Biological | Aimmune Therapeutics, Inc. | $24.10 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $19.40 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $18.61 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $16.58 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.84 | 1 | 2025 |
Source payment records
|
|||||
| UZEDY Normalized: uzedy |
Drug | Teva Pharmaceuticals USA, Inc. | $15.05 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $14.44 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 43 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 26 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 14 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| ZENPEP zenpep |
2025 | Zenpep | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. Exact reporting entity; no affiliate inference |
2025 | ZENPEP open payments reported associated product |
CMS Open Payments — General Payments 32144 supporting records · 12432 recipient NPIs · example record 1249641927 |
Zenpep · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
91 | 13 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
55 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
67 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
72 | 13 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
43 | suppressed by CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1965 | 310 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1781 | 292 |
| Gabapentin | Gabapentin | 1494 | 237 |
| Potassium Chloride | Potassium Chloride | 1265 | 195 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1209 | 173 |
| Trazodone Hcl | Trazodone Hcl | 1100 | 162 |
| Furosemide | Furosemide | 935 | 150 |
| Losartan Potassium | Losartan Potassium | 933 | 160 |
| Tamsulosin Hcl | Tamsulosin Hcl | 878 | 138 |
| Pantoprazole Sodium | Pantoprazole Sodium | 866 | 145 |
| Lisinopril | Lisinopril | 857 | 124 |
| Eliquis | Apixaban | 762 | 96 |
| Mirtazapine | Mirtazapine | 761 | 121 |
| Hydrochlorothiazide | Hydrochlorothiazide | 694 | 123 |
| Hydralazine Hcl | Hydralazine Hcl | 661 | 111 |
| Memantine Hcl | Memantine Hcl | 653 | 97 |
| Omeprazole | Omeprazole | 651 | 120 |
| Meloxicam | Meloxicam | 645 | 114 |
| Quetiapine Fumarate | Quetiapine Fumarate | 636 | 98 |
| Divalproex Sodium | Divalproex Sodium | 620 | 98 |
| Metformin Hcl | Metformin Hcl | 598 | 86 |
| Escitalopram Oxalate | Escitalopram Oxalate | 589 | 81 |
| Donepezil Hcl | Donepezil Hcl | 546 | 84 |
| Metoprolol Tartrate | Metoprolol Tartrate | 534 | 94 |
| Metoprolol Succinate | Metoprolol Succinate | 503 | 91 |
| Tramadol Hcl | Tramadol Hcl | 468 | 121 |
| Sertraline Hcl | Sertraline Hcl | 457 | 62 |
| Carvedilol | Carvedilol | 397 | 63 |
| Buspirone Hcl | Buspirone Hcl | 390 | 57 |
| Clopidogrel | Clopidogrel Bisulfate | 376 | 59 |
| Olanzapine | Olanzapine | 367 | 47 |
| Glimepiride | Glimepiride | 355 | 56 |
| Levetiracetam | Levetiracetam | 335 | 48 |
| Simvastatin | Simvastatin | 320 | 56 |
| Citalopram Hbr | Citalopram Hydrobromide | 285 | 47 |
| Sucralfate | Sucralfate | 282 | 41 |
| Atenolol | Atenolol | 268 | 30 |
| Famotidine | Famotidine | 266 | 52 |
| Pravastatin Sodium | Pravastatin Sodium | 253 | 38 |
| Lorazepam | Lorazepam | 244 | 61 |
| Januvia | Sitagliptin Phosphate | 229 | 34 |
| Tizanidine Hcl | Tizanidine Hcl | 229 | 67 |
| Clonidine | Clonidine | 227 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 219 | 95 |
| Allopurinol | Allopurinol | 219 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 214 | 43 |
| Finasteride | Finasteride | 210 | 34 |
| Nifedipine Er | Nifedipine | 206 | 38 |
| Fluoxetine Hcl | Fluoxetine Hcl | 202 | 30 |
| Entresto | Sacubitril/Valsartan | 199 | 16 |
| Jardiance | Empagliflozin | 195 | 37 |
| Pioglitazone Hcl | Pioglitazone Hcl | 192 | 24 |
| Baclofen | Baclofen | 191 | 25 |
| Trulicity | Dulaglutide | 188 | 31 |
| Pregabalin | Pregabalin | 180 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 178 | 66 |
| Clonidine Hcl | Clonidine Hcl | 177 | 53 |
| Spironolactone | Spironolactone | 173 | 29 |
| Montelukast Sodium | Montelukast Sodium | 171 | 32 |
| Risperidone | Risperidone | 168 | 30 |
| Cefuroxime | Cefuroxime Axetil | 164 | 121 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 164 | 45 |
| Ezetimibe | Ezetimibe | 160 | 32 |
| Latanoprost | Latanoprost | 157 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 156 | 40 |
| Oxybutynin Chloride | Oxybutynin Chloride | 155 | 22 |
| Rybelsus | Semaglutide | 151 | 36 |
| Glipizide | Glipizide | 149 | 28 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 146 | 20 |
| Benztropine Mesylate | Benztropine Mesylate | 143 | 17 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 142 | 27 |
| Amitriptyline Hcl | Amitriptyline Hcl | 138 | 22 |
| Aripiprazole | Aripiprazole | 134 | 23 |
| Levofloxacin | Levofloxacin | 128 | 98 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 127 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 126 | 61 |
| Clonazepam | Clonazepam | 123 | 22 |
| Ozempic | Semaglutide | 123 | 28 |
| Bupropion Xl | Bupropion Hcl | 122 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 121 | 18 |
| Alendronate Sodium | Alendronate Sodium | 120 | 17 |
| Xarelto | Rivaroxaban | 120 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 116 | 85 |
| Topiramate | Topiramate | 112 | 27 |
| Niacin Er | Niacin | 109 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 108 | 12 |
| Nystatin | Nystatin | 107 | 52 |
| Azithromycin | Azithromycin | 106 | 91 |
| Linzess | Linaclotide | 105 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 103 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 102 | 39 |
| Memantine Hcl Er | Memantine Hcl | 100 | 14 |
| Propranolol Hcl | Propranolol Hcl | 99 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 98 | 24 |
| Methylprednisolone | Methylprednisolone | 98 | 72 |
| Diclofenac Sodium | Diclofenac Sodium | 97 | 39 |
| Prednisone | Prednisone | 95 | 33 |
| Ipratropium Bromide | Ipratropium Bromide | 94 | 57 |
| Lactulose | Lactulose | 94 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 93 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 92 | 14 |
| Myrbetriq | Mirabegron | 91 | 13 |
| Alprazolam | Alprazolam | 86 | 21 |
| Megestrol Acetate | Megestrol Acetate | 86 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 84 | 19 |
| Valsartan | Valsartan | 84 | 17 |
| Novolin R | Insulin Regular, Human | 82 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 82 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 82 | 14 |
| Trimethoprim | Trimethoprim | 81 | 14 |
| Lithium Carbonate | Lithium Carbonate | 80 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 79 | 28 |
| Amiodarone Hcl | Amiodarone Hcl | 76 | 17 |
| Venlafaxine Hcl | Venlafaxine Hcl | 76 | suppressed |
| Lamotrigine | Lamotrigine | 72 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 72 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 71 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 70 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 69 | 13 |
| Lubiprostone | Lubiprostone | 68 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 67 | suppressed |
| Movantik | Naloxegol Oxalate | 67 | suppressed |
| Torsemide | Torsemide | 66 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 37 |
| Fluconazole | Fluconazole | 62 | 45 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 62 | 20 |
| Timolol Maleate | Timolol Maleate | 61 | 14 |
| Hydrocortisone | Hydrocortisone | 58 | 21 |
| Haloperidol | Haloperidol | 56 | 11 |
| Brilinta | Ticagrelor | 55 | suppressed |
| Cilostazol | Cilostazol | 55 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 55 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 55 | 15 |
| Warfarin Sodium | Warfarin Sodium | 55 | suppressed |
| Bumetanide | Bumetanide | 54 | 12 |
| Gemtesa | Vibegron | 54 | suppressed |
| Diazepam | Diazepam | 53 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 53 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 52 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 51 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 50 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 50 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 50 | 11 |
| Phenytoin | Phenytoin | 49 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 49 | 18 |
| Bydureon Bcise | Exenatide Microspheres | 47 | suppressed |
| Colchicine | Colchicine | 47 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 18 |
| Ondansetron Odt | Ondansetron | 46 | 37 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 45 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 44 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 44 | 12 |
| Loperamide | Loperamide Hcl | 44 | 26 |
| Glipizide Er | Glipizide | 43 | suppressed |
| Ingrezza | Valbenazine Tosylate | 43 | suppressed |
| Digoxin | Digoxin | 42 | suppressed |
| Xtampza Er | Oxycodone Myristate | 42 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 40 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 40 | suppressed |
| Temazepam | Temazepam | 40 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 39 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | 14 |
| Rivastigmine | Rivastigmine Tartrate | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 31 |
| Mounjaro | Tirzepatide | 35 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 35 | 34 |
| Solifenacin Succinate | Solifenacin Succinate | 35 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 35 | suppressed |
| Levemir | Insulin Detemir | 34 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 25 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 33 | 14 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 33 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 32 | suppressed |
| Paliperidone Er | Paliperidone | 31 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 30 | 11 |
| Zenpep | Lipase/Protease/Amylase | 30 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 29 | suppressed |
| Humulin R | Insulin Regular, Human | 29 | suppressed |
| Novolog | Insulin Aspart | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 27 |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 27 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 14 |
| Ramipril | Ramipril | 27 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 26 | suppressed |
| Calcium Acetate | Calcium Acetate | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | 11 |
| Rexulti | Brexpiprazole | 26 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 25 | suppressed |
| Ertapenem | Ertapenem Sodium | 25 | 16 |
| Hysingla Er | Hydrocodone Bitartrate | 25 | suppressed |
| Insulin Lispro | Insulin Lispro | 25 | suppressed |
| Dutasteride | Dutasteride | 24 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 24 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Methotrexate | Methotrexate Sodium | 24 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Carbamazepine | Carbamazepine | 23 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 23 | suppressed |
| Ibuprofen | Ibuprofen | 23 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 23 | 11 |
| Lacosamide | Lacosamide | 23 | suppressed |
| Metronidazole | Metronidazole | 23 | 16 |
| Mitigare | Colchicine | 23 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 23 | suppressed |
| Trospium Chloride | Trospium Chloride | 23 | suppressed |
| Scopolamine | Scopolamine | 22 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 22 | suppressed |
| Verapamil Sr | Verapamil Hcl | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 21 | suppressed |
| Cephalexin | Cephalexin | 21 | 14 |
| Estradiol | Estradiol | 21 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 21 |
| Primidone | Primidone | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | 13 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 19 | suppressed |
| Celecoxib | Celecoxib | 19 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | 14 |
| Rivastigmine | Rivastigmine | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Phenobarbital | Phenobarbital | 18 | suppressed |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Enulose | Lactulose | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 17 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 16 | suppressed |
| Cyclosporine | Cyclosporine | 16 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 16 | suppressed |
| Letrozole | Letrozole | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Clozapine | Clozapine | 15 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 15 | 11 |
| Multaq | Dronedarone Hcl | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Admelog | Insulin Lispro | 14 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Ibu | Ibuprofen | 14 | suppressed |
| Xifaxan | Rifaximin | 14 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Belbuca | Buprenorphine Hcl | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Hydroxyurea | Hydroxyurea | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 13 | suppressed |
| Tresiba | Insulin Degludec | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Azopt | Brinzolamide | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 12 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 12 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Trueplus Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 11 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 11 | suppressed |
| Minoxidil | Minoxidil | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Rytary | Carbidopa/Levodopa | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $591.99 · 25 records | Teva Pharmaceuticals USA, Inc. | AIRSUPRA, AUSTEDO XR, BREZTRI, Cologuard Collection Kit, FREESTYLE LIBRE 3, INGREZZA, REXULTI, UZEDY, VOQUEZNA, VOWST, Veozah, XIFAXAN, ZENPEP | 9 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Aimmune Therapeutics, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error